NF1 and neurofibroma: When we dichotomized benign neurofibromas based on NF1 syndrome status, only 14% (2 of 14) of sporadic neurofibromas harbored somatic NF1 gene mutations, which suggests sporadic neurofibromas may have different mechanism of RAS pathway activation.